Approval · Notice of Compliance 21856 · 2019
OXERVATE: Notice of Compliance 21856
Issued February 8, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21856
- Date
- February 8, 2019
- Company
- Dompé Farmaceutici S.P.A.Milano, Milan, Italy
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXERVATE | 02485613 | Cancelled Post Market |
Medicinal ingredients
- CENEGERMIN 20 MCG per ML